BIOSIMILARS Two biosimilars get US panel's nod

被引：0

|

作者：

Mccoy, Michael

机构：

来源：

CHEMICAL & ENGINEERING NEWS | 2016年 / 94卷 / 29期

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

收藏

页码：15 / 15

页数：1

相关论文

共 50 条

[11] First biosimilars trickle into US pathway
Nature Biotechnology, 2014, 32 : 855 - 855
[12] US state legislation on biosimilars substitution
Derbyshire, Michelle
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2013, 2 (03): : 155 - 156
[13] FDA Guides the Way to Biosimilars in the US
Drakulich, Angie
Pharmaceutical Technology, 2012, 36 (03)
[14] Challenges and Opportunities for Biosimilars Developers in the US
Ritter, Amy
Barry, Nora
BIOPHARM INTERNATIONAL, 2012, 25 (09) : 24 - 25
[15] FDA Guides the Way to Biosimilars in the US
Drakulich, Angie
BIOPHARM INTERNATIONAL, 2012, 25 (03) : 8 - 8
[16] US PAYER EXPECTATIONS FOR REIMBURSEMENT OF BIOSIMILARS
Malik, A. N.
Keeping, K.
Fletcher-Louis, M.
VALUE IN HEALTH, 2015, 18 (07) : A545 - A545
[17] Celltrion's infliximab copy shows path to biosimilars in US
von Schaper, Eva
NATURE BIOTECHNOLOGY, 2016, 34 (05) : 454 - 455
[18] Factors influencing the economics of biosimilars in the US
Mehr, Stanton R.
Brook, Richard A.
JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (12) : 1268 - 1271
[19] Biosimilars markets: US and EU compared
Bird, Eleanor
Derbyshire, Michelle
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2020, 9 (02): : 90 - 92
[20] Biosimilars Approvals in the US: The Path Forward
Engel, John M.
BIOPHARM INTERNATIONAL, 2010, 23 (09) : 46 - +

← 1 2 3 4 5 →